Fourth project team meeting in Stockholm

During the 23th EHA congress in Stockholm, Sweden, we have had the opportunity to host our fourth HORIZON 2020 project team meeting. We had an interactive session in which we discussed the project progress and short term future goals. The meeting was finalized by...

Two-year anniversary!

This month we celebrate the two-year anniversary of our Multiple Myeloma Horizon 2020 research project. Within this period we have made considerable progress towards our central goal of developing a personalized medicine tool that is capable of predicting the most...

HORIZON 2020 – Patient Questionnaire

Myeloma Patients Europe (MPE) is running a survey for European myeloma patients to understand their quality of life and how this is impacted by treatment side-effects.   To gain knowledge about the current Multiple Myeloma (MM) disease situation in Europe, we ask MM...

Summary of the first project year

The Multiple Myeloma horizon 2020 (MMh2020) initiative was started on November 1st 2016 and included the following consortium partners: SkylineDx B.V., the Department of Haematology of the Erasmus University Medical Center Rotterdam (Erasmus MC), the Department of...

© MMH2020